Liver disease related to the heart

Transplantation Reviews

Volumn 29, Issue 1, 2015, Pages 33-37

  Ford, Ryan M ^a   Book, Wendy ^b   Spivey, James R ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; AWARENESS; CARDIAC CIRRHOSIS; CARDIAC PATIENT; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGESTIVE HEPATOPATHY; FONTAN LIVER DISEASE; HEART DISEASE; HEART FAILURE; HEART GRAFT; HEPATITIS; HUMAN; ISCHEMIC HEPATITIS; ISOLATED ORGAN; LIVER DISEASE; LIVER GRAFT; PREVALENCE; PROGNOSIS; REVIEW; CHRONIC DISEASE; COMPLICATION; HEART DISEASES; LIVER DISEASES;

ACUTE DISEASE; CHRONIC DISEASE; HEART DISEASES; HUMANS; LIVER DISEASES;

EID: 84916608487     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.11.003     Document Type: Review

References (50)

1. Rychik J., Veldtman G., Rand E., et al. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 2012, 33:1001-1012.
2. Samsky M.D., Patel C.B., DeWald T.A., et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol 2013, 61:2397-2405.
3. Henrion J., Schapira M., Luwaert R., Colin L., Delannoy A., Heller F.R. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003, 82:392-406.
4. Seeto R.K., Fenn B., Rockey D.C. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000, 109:109-113.
5. Birrer R., Takuda Y., Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007, 46:1063-1070.
6. Asrani S.K., Asrani N.S., Freese D.K., et al. Congenital heart disease and the liver. Hepatology 2012, 56:1160-1169.
7. Cassidy W.M., Reynolds T.B. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994, 19:118-121.
8. Brosnan M.E., Brosnan J.T. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am J Clin Nutr 2009, 90:857S-861S.
9. Caraceni P., Bianchi C., Domenicali M., et al. Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury. J Hepatol 2004, 41:82-88.
10. Giallourakis C.C., Rosenberg P.M., Friedman L.S. The liver in heart failure. Clin Liver Dis 2002, 6:947-967. [viii-ix].
11. Boland E.W., Willius F.A. Changes in the liver produced by chronic passive congestion; with special reference to the problem of cardiac cirrhosis. Arch Intern Med 1938, 62:723-739.
12. Fuhrmann V., Kneidinger N., Herkner H., et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009, 35:1397-1405.
13. Myers R.P., Cerini R., Sayegh R., et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 2003, 37:393-400.
14. Toris G.T., Bikis C.N., Tsourouflis G.S., Theocharis S.E. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011, 17:RA53-RA63.
15. Vasconcelos L.A., de Almeida E.A., Bachur L.F. Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure. Arq Bras Cardiol 2007, 88:590-595.
16. van Deursen V.M., Damman K., Hillege H.L., van Beek A.P., van Veldhuisen D.J., Voors A.A. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 2010, 16:84-90.
17. Richman S.M., Delman A.J., Grob D. Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 1961, 30:211-225.
18. Matthews J.C., Koelling T.M., Pagani F.D., Aaronson K.D. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51:2163-2172.
19. Naschitz J.E., Slobodin G., Lewis R.J., Zuckerman E., Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000, 140:111-120.
20. Wanless I.R., Liu J.J., Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995, 21:1232-1237.
21. Horwich T.B., Kalantar-Zadeh K., MacLellan R.W., Fonarow G.C. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008, 155:883-889.
22. Warnes C.A., Williams R.G., Bashore T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e143-e263.
23. Marelli A.J., Mackie A.S., Ionescu-Ittu R., Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007, 115:163-172.
24. Khairy P., Poirier N., Mercier L.A. Univentricular heart. Circulation 2007, 115:800-812.
25. Fontan F., Baudet E. Surgical repair of tricuspid atresia. Thorax 1971, 26:240-248.
26. Jonas R.A., Castaneda A.R. Modified Fontan procedure: atrial baffle and systemic venous to pulmonary artery anastomotic techniques. J Card Surg 1988, 3:91-96.
27. Davies R.R., Chen J.M., Mosca R.S. The Fontan procedure: evolution in technique; attendant imperfections and transplantation for "failure". Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011, 14:55-66.
28. Khairy P., Fernandes S.M., Mayer J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008, 117:85-92.
29. Ghaferi A.A., Hutchins G.M. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005, 129:1348-1352.
30. Kiesewetter C.H., Sheron N., Vettukattill J.J., et al. Hepatic changes in the failing Fontan circulation. Heart 2007, 93:579-584.
31. Senzaki H., Masutani S., Kobayashi J., et al. Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts. Circulation 2002, 105:2885-2892.
32. Kendall T.J., Stedman B., Hacking N., et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 2008, 61:504-508.
33. Camposilvan S., Milanesi O., Stellin G., Pettenazzo A., Zancan L., D'Antiga L. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008, 86:177-182.
34. Bryant T., Ahmad Z., Millward-Sadler H., et al. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol 2011, 151:268-272.
35. Zhang Q.Q., Zu M.H., Xu H., Gu Y.M., Wang W.L., Gao Z.K. Combining angioplasty with percutaneous microwave ablation for treating primary Budd-Chiari syndrome associated with hepatocellular carcinoma in two patients: a case report. Oncol Lett 2013, 6:612-616.
36. Matsui S., Ichida T., Watanabe M., et al. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 2000, 15:1205-1211.
37. Kew M.C., McKnight A., Hodkinson J., Bukofzer S., Esser J.D. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989, 9:121-125.
38. Shrestha S.M. Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava. Hepatol Int 2009, 3:392-402.
39. Mueller S., Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepatol Med 2010, 2:49-67.
40. Baek J.S., Bae E.J., Ko J.S., et al. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 2010, 96:1750-1755.
41. Wu F.M., Ukomadu C., Odze R.D., Valente A.M., Mayer J.E., Earing M.G. Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011, 6:190-201.
42. Elder R.W., McCabe N.M., Hebson C., et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol 2013, 168:3764-3769.
43. Jayakumar K.A., Addonizio L.J., Kichuk-Chrisant M.R., et al. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol 2004, 44:2065-2072.
44. Dichtl W., Vogel W., Dunst K.M., et al. Cardiac hepatopathy before and after heart transplantation. Transpl Int 2005, 18:697-702.
45. Chokshi A., Cheema F.H., Schaefle K.J., et al. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant 2012, 31:591-600.
46. Concejero A., Chen C.L., Liang C.D., et al. Atrial septal defect in end-stage liver disease children before and after liver transplantation. Surgery 2008, 143:271-277.
47. Krowka M.J., Miller D.P., Barst R.J., et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest 2012, 141:906-915.
48. Porrett P.M., Desai S.S., Timmins K.J., Twomey C.R., Sonnad S.S., Olthoff K.M. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transpl 2004, 10:1539-1544.
49. Raichlin E., Daly R.C., Rosen C.B., et al. Combined heart and liver transplantation: a single-center experience. Transplantation 2009, 88:219-225.
50. Te H.S., Anderson A.S., Millis J.M., Jeevanandam V., Jensen D.M. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008, 27:753-759.